参考文献/References:
[1] Juraszek A,Czerny M,Rylski B. Update in aortic dissection[J]. Trends Cardiovasc Med,2022,32(7):456-461.
[2] Hameed I,Cifu AS,Vallabhajosyula P. Management of thoracic aortic dissection[J]. JAMA,2023,329(9):756-757.
[3] Sherk WM,Khaja MS,Williams DM. Anatomy,pathology,and classification of aortic dissection[J]. Tech Vasc Interv Radiol,2021,24(2):100746.
[4] Zhou Z,Cecchi AC,Prakash SK,et al. Risk factors for thoracic aortic dissection[J].Genes(Basel),2022,13(10):1814.
[5] Bossone E,Eagle KA. Epidemiology and management of aortic disease:aortic aneurysms and acute aortic syndromes[J]. Nat Rev Cardiol,2021,18(5):331-348.
[6] Evangelista A,Isselbacher EM,Bossone E,et al. Insights from the international registry of acute aortic dissection:a 20-year experience of collaborative clinical research[J]. Circulation,2018,137(17):1846-1860.
[7] Nienaber CA,Clough RE,Sakalihasan N,et al. Aortic dissection[J]. Nat Rev Dis Primers ,2016,21(2):16053.
[8] Inoue T,Emoto T,Yamanaka K,et al. Intense impact of IL-1β expressing inflammatory macrophages in acute aortic dissection[J]. Sci Rep,2024,14(1):14893.
[9] Song J,Peng H,Lai M,et al. Relationship between inflammatory-related cytokines with aortic dissection[J]. Int Immunopharmacol,2023,122:110618.
[10] Li X,Liu D,Zhao L,et al. Targeted depletion of monocyte/macrophage suppresses aortic dissection with the spatial regulation of MMP-9 in the aorta[J]. Life Sciences,2020,254:116927.
[11] Warren EB,Gordon-Lipkin EM,Cheung F,et al. Inflammatory and interferon gene expression signatures in patients with mitochondrial disease[J]. J Transl Med,2023,21(1):331.
[12] Shen YH,LeMaire SA,Webb NR,et al. Aortic aneurysms and dissections series[J]. Arterioscler Thromb Vasc Biol,2020,40(3):37-46.
[13] Hidalgo A,Libby P,Soehnlein O,et al. Neutrophil extracellular traps:from physiology to pathology[J]. Cardiovasc Res,2022,118(13):2737-2753.
[14] Yang S,Xiao Y,Du Y,et al. Diagnostic and prognostic value of neutrophil extracellular trap levels in patients with acute aortic dissection[J]. Front Cardiovasc Med,2022,15(8):683445.
[15] Roth MT,Zhang ML,Arpin R,et al. Lymphocyte rings[J]. Diagn Cytopathol,2022,50(7):361-362.
[16] Zhang H,Dhalla NS. The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease[J]. Int J Mol Sci,2024,25(2):1082.
[17] Rigamonti A,Villar J,Segura E. Monocyte differentiation within tissues:a renewed outlook[J]. Trends Immunol,2023,44(12):999-1013.
[18] Ruder AV,Wetzels SMW,Temmerman L,et al. Monocyte heterogeneity in cardiovascular disease[J]. Cardiovasc Res,2023,119(11):2033-2045.
[19] Li D,Li J,Liu H,et al. Pathogenic Tconvs promote inflammatory macrophage polarization through GM-CSF and exacerbate abdominal aortic aneurysm formation[J]. FASEB J,2022,36(3):22172.
[20] Yin ZQ,Han H,Yan X,et al. Research progress on the pathogenesis of aortic dissection[J]. Curr Probl Cardiol,2023,48(8):101249.
[21] Wang X,Zhang H,Cao L,et al. The role of macrophages in aortic dissection[J]. Front Physiol,2020,11(1):54.
[22]Liu X,Liu J,Li Y,et al. The correlation between the inflammatory effects of activated macrophages in atherosclerosis and aortic dissection[J]. Ann Vasc Surg,2022,85:341-346.
[23]于福敏,张惠英,宿连政. 基于CTA基础下探究TNF-α、FDP和cTnⅠ在主动脉夹层中的应用价值[J]. 影像研究与医学应用,2021,5(11):226-227.
[24] Mortezaee K,Majidpoor J. Checkpoint inhibitor/interleukin-based combination therapy of cancer[J]. Cancer Med,2022,11(15):2934-2943.
[25] Huang Z,Liu Z,Wang K,et al. Reduced number and activity of circulating endothelial progenitor cells in acute aortic dissection and its relationship with IL-6 and IL-17[J]. Front Cardiovasc Med,2021,29(8):628462.
[26] Feng Y,Ye D,Wang Z,et al. The role of interleukin-6 family members in cardiovascular diseases[J]. Front Cardiovasc Med,2022,23(9):818890.
[27] Wu Q,Li J,Chen L,et al. Efficacy of interleukin-6 in combination with D-dimer in predicting early poor postoperative prognosis after acute stanford type a aortic dissection[J]. J Cardiothorac Surg,2020,15(1):172.
[28] Jia Y,Li D,Yu J,et al. Prognostic value of interleukin-33,sST2,myeloperoxidase,and matrix metalloproteinase-9 in acute aortic dissection[J]. Front Cardiovasc Med,2023,6(9):1084321.
[29] Ji C,Wang X,Xue B,et al. A fluorescent nano vector for early diagnosis and enhanced Interleukin-33 therapy of thoracic aortic dissection[J]. Biomaterials,2023,2(93):121958.
[30] Qi F,Liu Y,Zhang K,et al. Artificial intelligence uncovers natural MMP inhibitor crocin as a potential treatment of thoracic aortic aneurysm and dissection[J]. Front Cardiovasc Med,2022,6(9):871486.
[31] Zhang C,Niu K,Ren M,et al. Targeted inhibition of matrix metalloproteinase-8 prevents aortic dissection in a murine model[J]. Cells,2022,11(20):3218.
[32] Chang TT,Liao LY,Chen JW. Inhibition on CXCL5 reduces aortic matrix metalloproteinase 9 expression and protects against acute aortic dissection[J]. Vascul Pharmacol,2021,141:106926.
[33] Ma W,Liu A,Wu X,et al. The intricate role of CCL5/CCR5 axis in Alzheimer disease[J]. J Neuropathol Exp Neurol,2023,82(11):894-900.
[34] 李婵,刘月娥,雷雪,等. 全身免疫炎症指数与急性主动脉夹层患者短期预后的关系[J]. 心脑血管病防治,2024,24(4):6-9.
[35] Xu H,Wang H,Wu L,et al. Prognostic value of systemic inflammation response index in acute type a aortic dissection[J]. World J Surg,2023,47(10):2554-2561.
[36] 纪沛君,张诚,陈丹,等. Stanford A型主动脉夹层术后合并低氧血症的临床特征、预后及影响因素分析[J]. 解放军医学杂志,2022,47(4):353-358.
[37] Yokoyama Y,Tsukagoshi J,Hamlin S,et al. Endovascular therapy for Stanford B aortic dissection for patients with Marfan Syndrome:systematic review and meta-analysis[J]. J Cardiovasc Surg (Torino) ,2023,64(1):41-47.
[38] Su S,Liu J,Chen L,et al. Systemic immune-inflammation index predicted the clinical outcome in patients with type-B aortic dissection undergoing thoracic endovascular repair[J]. Eur J Clin Invest ,2022,52(2):13692.
[39] 李启峰,高涌. 炎性指标及D-二聚体水平与急性Stanford B型主动脉夹层患者术后短期不良事件的相关性分析[J]. 中国血管外科杂志(电子版),2023,15(3):238-242.
相似文献/References:
[1]孙静美 尹德春 曲秀芬.炎症信号与心房颤动[J].心血管病学进展,2020,(1):31.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.009]
SUN Jingmei,YIN Dechun,QU Xiufen.Inflammatory Signals Associated with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2020,(2):31.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.009]
[2]朱晓龙侯阳.细胞焦亡的分子机制其在心血管病变中的研究进展[J].心血管病学进展,2020,(8):847.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.016]
ZHU Xiaolong,HOU Yang.Molecular Mechanism of yroptosis and Its Research Progress in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(2):847.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.016]
[3]赵琳 孟旭 周宪梁.正常高值血压人群血清炎性标志物研究进展[J].心血管病学进展,2020,(11):1116.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
ZHAO Lin,MENG Xu,ZHOU Xianliang.Serum Inflammatory Markers in Population with High Normal Blood Pressure[J].Advances in Cardiovascular Diseases,2020,(2):1116.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[4]董正 吴润达 姚康 葛均波.免疫细胞在动脉粥样硬化炎症进展中的双刃剑作用[J].心血管病学进展,2021,(1):26.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
DONG Zheng,WU Runda,YAO Kang,et al.Double-edged Sword Role of Immune Cells in Advance of Atherosclerotic Inflammation[J].Advances in Cardiovascular Diseases,2021,(2):26.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
[5]张菲菲 周子皓 王芳.白介素在血管钙化作用机制中的研究进展[J].心血管病学进展,2021,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.018]
HANG Feifei,ZHOU Zihao,WANG Fang?/html>.Research Progress of Interleukin in the Mechanism?f Vascular Calcification[J].Advances in Cardiovascular Diseases,2021,(2):364.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.018]
[6]魏天天?王学超?吴海波?杜荣品.心力衰竭生物标志物的研究进展[J].心血管病学进展,2021,(7):610.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.009]
WEI Tiantian,WANG Xuechao,WU Haibo,et al.Biomarkers of Heart Failure[J].Advances in Cardiovascular Diseases,2021,(2):610.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.009]
[7]王兰 叶玉兰 宁明安 张迪 尚粉青.血清PCSK9水平与PCI后冠状动脉病变再进展的关系研究[J].心血管病学进展,2022,(7):667.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
WANG Lan,YE Yulan,NING Mingan,et al.Correlation Analysis Between Serum PCSK9 Level and Coronary Artery Pathological ?Progression After PCI[J].Advances in Cardiovascular Diseases,2022,(2):667.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[8]王朝阳 赵丽娜 田师鹏 陈淑霞 谷剑.炎症治疗在动脉粥样硬化中的研究进展[J].心血管病学进展,2023,(6):519.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.009]
WANG Zhaoyang,ZHAO Lina,TIAN Shipeng,et al.Advances in the Treatment of Inflammation in Atherosclerosis[J].Advances in Cardiovascular Diseases,2023,(2):519.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.009]
[9]张晓婷 郭衍楷 汤宝鹏.心房颤动与白介素家族的研究进展[J].心血管病学进展,2024,(4):340.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.012]
ZHANG Xiaoting,GUO Yankai,TANG Baopeng.Interleukin Family and Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2024,(2):340.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.012]